Dextromethorphan and guaifenesin use should be monitored diligently in individuals with "bad metabolizer" CYP2D6 enzyme concentrations and clients who will be sedated. This mixture medication has a massive median toxic dose (TD50) to median productive dose (ED50) ratio (or therapeutic index) in these individuals. 资助维基百科 外观 创建账号 登录 个人工具 创建账号 https://adb-butinacabestellen48023.ampblogs.com/new-step-by-step-map-for-dextromethorphan-dxm-for-sale-in-europe-66951359